Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'

Ann Oncol. 2018 Mar 1;29(3):774-775. doi: 10.1093/annonc/mdx747.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Medical Oncology*
  • Neoplasms*